Literature DB >> 17460099

Subthalamic stimulation and neuronal activity in the substantia nigra in Parkinson's disease.

D Maltête1, N Jodoin, C Karachi, J L Houeto, S Navarro, P Cornu, Y Agid, M L Welter.   

Abstract

High-frequency stimulation of the subthalamic nucleus (STN) is an effective treatment for severe forms of Parkinson's disease (PD). To study the effects of high-frequency STN stimulation on one of the main output pathways of the basal ganglia, single-unit recordings of the neuronal activity of the substantia nigra pars reticulata (SNr) were performed before, during, and after the application of STN electrical stimulation in eight PD patients. During STN stimulation at 14 Hz, no change in either the mean firing rate or the discharge pattern of SNr neurons was observed. STN stimulation at 140 Hz decreased the mean firing rate by 64% and the mean duration of bursting mode activity of SNr neurons by 70%. The SNr residual neuronal activity during 140-Hz STN stimulation was driven by the STN stimulation. How the decrease in rate and modification of firing pattern of SNr-evoked neural activity, during high-frequency STN stimulation, contribute to the improvement of parkinsonian motor disability remains to be elucidated.

Entities:  

Mesh:

Year:  2007        PMID: 17460099     DOI: 10.1152/jn.01104.2006

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  23 in total

1.  Gamma-aminobutyric acid(B) receptor activation suppresses stimulus-evoked burst firing in rat substantia nigra reticulata neurons.

Authors:  Ke-Zhong Shen; Steven W Johnson
Journal:  Neuroreport       Date:  2012-01-04       Impact factor: 1.837

2.  Site of deep brain stimulation and jaw velocity in Parkinson disease.

Authors:  Lee T Robertson; Rebecca J St George; Patricia Carlson-Kuhta; Penelope Hogarth; Kim J Burchiel; Fay B Horak
Journal:  J Neurosurg       Date:  2011-08-12       Impact factor: 5.115

3.  High-frequency microstimulation in human globus pallidus and substantia nigra.

Authors:  Myriam Lafreniere-Roula; Elaine Kim; William D Hutchison; Andres M Lozano; Mojgan Hodaie; Jonathan O Dostrovsky
Journal:  Exp Brain Res       Date:  2010-07-17       Impact factor: 1.972

4.  Complex EPSCs evoked in substantia nigra reticulata neurons are disrupted by repetitive stimulation of the subthalamic nucleus.

Authors:  Ke-Zhong Shen; Steven W Johnson
Journal:  Synapse       Date:  2008-04       Impact factor: 2.562

Review 5.  Selective GABA release as a mechanistic basis of high-frequency stimulation used for the treatment of neuropsychiatric diseases.

Authors:  Thomas J Feuerstein; Miriam Kammerer; Carl Hermann Lücking; Andreas Moser
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-05-02       Impact factor: 3.000

6.  The effect of striatal dopaminergic grafts on the neuronal activity in the substantia nigra pars reticulata and subthalamic nucleus in hemiparkinsonian rats.

Authors:  Timothy P Gilmour; Brigitte Piallat; Christopher A Lieu; Kala Venkiteswaran; Renuka Ramachandra; Anand N Rao; Andrew C Petticoffer; Matthew A Berk; Thyagarajan Subramanian
Journal:  Brain       Date:  2011-09-12       Impact factor: 13.501

7.  Regulation of polysynaptic subthalamonigral transmission by D2, D3 and D4 dopamine receptors in rat brain slices.

Authors:  Ke-Zhong Shen; Steven W Johnson
Journal:  J Physiol       Date:  2012-02-27       Impact factor: 5.182

8.  Deep brain stimulation does not silence neurons in subthalamic nucleus in Parkinson's patients.

Authors:  Jonathan D Carlson; Daniel R Cleary; Justin S Cetas; Mary M Heinricher; Kim J Burchiel
Journal:  J Neurophysiol       Date:  2009-12-02       Impact factor: 2.714

9.  Presynaptic serotonergic gating of the subthalamonigral glutamatergic projection.

Authors:  Shengyuan Ding; Li Li; Fu-Ming Zhou
Journal:  J Neurosci       Date:  2013-03-13       Impact factor: 6.167

10.  Group I mGluRs evoke K-ATP current by intracellular Ca2+ mobilization in rat subthalamus neurons.

Authors:  Ke-Zhong Shen; Steven W Johnson
Journal:  J Pharmacol Exp Ther       Date:  2013-01-18       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.